ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.

MOVEMENT DISORDERS PARKINSON'S DISEASE SCALES

Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
25 Jan 2024
Historique:
received: 11 09 2023
accepted: 10 01 2024
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 25 1 2024
Statut: aheadofprint

Résumé

NMF are currently poorly evaluated in therapeutic decisions. A quantification of their severity would facilitate their integration. The objective of this study was to validate an autoquestionnaire evaluating the severity of non-motor fluctuations (NMF) in Parkinson's disease (PD). Patients with PD were included in presurgical situation for deep brain stimulation of subthalamic nuclei. They participated in the PREDISTIM cohort (a study evaluating the predictive factors for therapeutic response of subthalamic stimulation in PD) in 17 centres in France. Our questionnaire, resulting from previous phases of development, included 11 non-motor symptoms (NMS). Their severity ranged from 0 to 10 and was assessed in OFF and then ON-Dopa to study their fluctuations. 310 patients were included, of whom 98.8% had NMS and 98.0% had NMF. Each NMS was significantly improved by L-Dopa (decrease in severity score ranging from 43.1% to 69.9%). Fatigue was the most frequent and most severe NMS. NMS were considered more bothersome than motor symptoms by 37.5% of patients in OFF-Dopa and 34.9% in ON-Dopa. This is the first questionnaire allowing a real-time quantification of the severity of NMS and their fluctuation with levodopa. It was able to confirm and measure the effect of L-dopa and show differences according to the patients and the NMS. It differs from other questionnaires by its measurement at a precise moment of the severity of the NMS, allowing its use during pretherapeutic assessments.Our questionnaire has been validated to measure the severity of NMF. It will be able to quantify the non-motor effect of anti-parkinsonian treatments and could facilitate the integration of NMF in therapeutic decisions.

Sections du résumé

BACKGROUND BACKGROUND
NMF are currently poorly evaluated in therapeutic decisions. A quantification of their severity would facilitate their integration. The objective of this study was to validate an autoquestionnaire evaluating the severity of non-motor fluctuations (NMF) in Parkinson's disease (PD).
METHODS METHODS
Patients with PD were included in presurgical situation for deep brain stimulation of subthalamic nuclei. They participated in the PREDISTIM cohort (a study evaluating the predictive factors for therapeutic response of subthalamic stimulation in PD) in 17 centres in France. Our questionnaire, resulting from previous phases of development, included 11 non-motor symptoms (NMS). Their severity ranged from 0 to 10 and was assessed in OFF and then ON-Dopa to study their fluctuations.
RESULTS RESULTS
310 patients were included, of whom 98.8% had NMS and 98.0% had NMF. Each NMS was significantly improved by L-Dopa (decrease in severity score ranging from 43.1% to 69.9%). Fatigue was the most frequent and most severe NMS. NMS were considered more bothersome than motor symptoms by 37.5% of patients in OFF-Dopa and 34.9% in ON-Dopa.
CONCLUSIONS CONCLUSIONS
This is the first questionnaire allowing a real-time quantification of the severity of NMS and their fluctuation with levodopa. It was able to confirm and measure the effect of L-dopa and show differences according to the patients and the NMS. It differs from other questionnaires by its measurement at a precise moment of the severity of the NMS, allowing its use during pretherapeutic assessments.Our questionnaire has been validated to measure the severity of NMF. It will be able to quantify the non-motor effect of anti-parkinsonian treatments and could facilitate the integration of NMF in therapeutic decisions.

Identifiants

pubmed: 38272656
pii: jnnp-2023-332551
doi: 10.1136/jnnp-2023-332551
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Luc Defebvre (L)
Nicolas Carriere (N)
Guillaume Grolez (G)
Gillaume Baille (G)
Jean-Pierre Pruvo Kreisler (JP)
Pr Leclerc (P)
Renaud Lopes (R)
Romain Viard (R)
Gregory Kuchcinski (G)
Julien Dumont (J)
Kathy Dujardin (K)
M Delliaux (M)
M Brion (M)
Gustavo Touzet (G)
Nicolas Reyns (N)
Arnaud Delval (A)
Valerie Santraine (V)
Marie Pleuvret (M)
Nolwen Dautrevaux (N)
Victor Laugeais (V)
Morgane Coeffet (M)
Thavarak Ouk (T)
Camille Potey (C)
Celine Leclercq (C)
Elise Gers (E)
Jean-Christophe Corvol (JC)
Marie Vidailhet (M)
Marie-Laure Welter (ML)
Lucette Lacomblez (L)
David Grabli (D)
Emmanuel Roze (E)
Yulia Worbe (Y)
Cécile Delorme (C)
Hana You (H)
Jonas Ihle (J)
Raquel Guimeraes-Costa (R)
Florence Cormier-Dequaire (F)
Aurélie Méneret (A)
Andréas Hartmann (A)
Louise-Laure Mariani (LL)
Stéphane Lehericy (S)
Virginie Czernecki (V)
Fanny Pineau (F)
Frédérique Bozon (F)
Camille Huiban (C)
Eve Benchetrit (E)
Carine Karachi (C)
Soledad Navarro (S)
Philippe Cornu (P)
Arlette Welaratne (A)
Carole Dongmo-Kenfack (C)
Lise Mantisi (L)
Nathalie Jarry (N)
Sophie Aix (S)
Carine Lefort (C)
Philippe Damier (P)
Pascal Derkinderen (P)
Anne-Gaelle Corbille (AG)
Elisabeth Calvier-Auffray (E)
Madame Laetitia Rocher (ML)
Madame Anne-Laure Deruet (MA)
Raoul Sylvie (R)
Roualdes Vincent (R)
Le Dily Séverine (LD)
Berangere Debilly (B)
Franck Durif (F)
Philippe Derost (P)
Charlotte Beal (C)
Carine Chassain (C)
Laure Delaby (L)
Tiphaine Vidal (T)
Jean Jeacques Lemaire (JJ)
Isabelle Rieu (I)
Elodie Durand (E)
Frédérique Fluchère (F)
Stephan Grimaldi (S)
Nadine Girard (N)
Eve Benchetrit (E)
Marie Delfini (M)
Romain Carron (R)
Jean Regis (J)
Giorgio Spatola (G)
Camille Magnaudet (C)
Ansquer Solène (A)
Colin Olivier (C)
J L Houeto (JL)
Guillevin Remy (G)
Fradet Anne (F)
Anziza Manssouri (A)
Blondeau Sophie (B)
Richard Philippe (R)
Cam Philippe (C)
Page Philippe (P)
Bataille Benoit (B)
Rabois Emilie (R)
Guillemain Annie (G)
Frédérique Leh (F)
Alexandre Bonnet (A)
Marc Vérin (M)
Jean-Christophe Ferré (JC)
Jean François Houvenaghel (JF)
Claire Haegelen (C)
Francoise Kestens (F)
Solenn Ory (S)
Pierre Burbaud (P)
Nathalie Damon-Perriere (N)
Wassilios Meissner (W)
Francois Tison (F)
Stéphanie Bannier (S)
Elsa Krim (E)
Sandrine Molinier-Blossier (S)
Morgan Ollivier (M)
Marion Lacoste (M)
Nicolas Auzou (N)
Marie Bonnet (M)
Emmanuel Cuny (E)
Julien Engelhardt (J)
Olivier Branchard (O)
Clotilde Huet (C)
Julie Blanchard (J)
Fabienne Ory Magne (FO)
Marion Simonetta Moreau (MS)
Christophe Arbus (C)
Fabrice Bonnevilleet (F)
Jean Albert Lotterie (JA)
Marion Sarrail (M)
Patrick Chaynes (P)
François Caire (F)
Estelle Harroch (E)
Romain Lefaucheur (R)
Damien Fetter (D)
Nicolas Magne (N)
Sandrine Bioux (S)
Maud Loubeyre (M)
Evangéline Bliaux (E)
Dorothée Pouliquen (D)
Stéphane Derrey (S)
Linda Vernon (L)
Frédéric Ziegler (F)
Ouhaid Lagha-Boukbiza (O)
Christine Tranchant (C)
Odile Gebus (O)
Solveig Montaut (S)
Stéphane Kremer (S)
Nadine Longato (N)
Clélie Phillips (C)
Jimmy Voirin (J)
Marie desNeiges Santin (MD)
Dominique Chaussemy (D)
Amaury Mengin (A)
Claire Marsé (C)
Lydiane Mondot (L)
Bruno Giordana (B)
Robin Kardous (R)
Bernadette Bailet (B)
Héloise Joly (H)
Denys Fontaine (D)
Aurélie Leplus (A)
Amélie Faustini (A)
Vanessa Ferrier (V)
Pierre Krystkowiak (P)
Jean-Marc Constans (JM)
Sandrine Wannepain (S)
Audrey Seling (A)
Michel Lefranc (M)
Stéphanie Blin (S)
Béatrice Schuler (B)
Stephane Thobois (S)
Teodor Danaila (T)
Yves Berthezene (Y)
Roxana Ameli (R)
Helene Klinger (H)
Gustavo Polo (G)
Patrick Mertens (P)
A Nunes (A)
Elise Metereau (E)
Solène Frismand (S)
Emmanuelle Schmitt (E)
Mylène Meyer (M)
Céline Dillier (C)
Sophie Colnat (S)
Anne Chatelain (A)
Jean-Philippe Brandel (JP)
Patte Karsenti (P)
Marie Lebouteux (M)
Marc Ziegler (M)
Christine Delmaire (C)
Julien Savatowky (J)
Juliette Vrillac (J)
Claire Nakache (C)
Vincent D'HardemareLhaouas Belamri (VD)
Valérie Mesnage (V)
Cécilia Bonnet (C)
Jarbas Correa (J)
Lino Junior (L)
Camille Decrocq (C)
Anne Boulin (A)
Stéphanie Auliac-Condette (S)
Julie Gratieux (J)
Dilanda Terfaia (D)
Bérénice Gardel (B)
Delphine Lopez (D)
Lydie Prette (L)
Fantoumata Sacko (F)
Catherine Ziz (C)
David Gay (D)
Robin Bonicel (R)
Fouzia El Mountassir (FE)
Clara Fischer (C)
Jean-François Mangin (JF)
Marie Chupin (M)
Yann Cointepas (Y)
Bertrand Accart (B)
Patrick Gelé (P)
Florine Fievet (F)
Matthieu Chabel (M)
Virginie Derenaucourt (V)
Loïc Facon (L)
Yanick Tchantchou Njosse (YT)
Dominique Deplanque (D)
Alain Duhamel (A)
Lynda Djemmane (L)
Florence Duflot (F)
Hajar Chouiki (H)

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Florent Faggianelli (F)

Neurology, CHU Timone, Marseille, France Florent.faggianelli@gmail.com.

Tatiana Witjas (T)

Department of Neurology, University Hospital Timone, Marseille, France.

J-P Azulay (JP)

CHU Timone, Marseille, France.

Isabelle Benatru (I)

Centre Hospitalier Universitaire de Poitiers, Poitiers, France.

Cécile Hubsch (C)

Neurology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Mathieu Anheim (M)

Service de Neurologie, Hopital de Hautepierre, Strasbourg, France.

Caroline Moreau (C)

Neurology Expert Center for Parkinson's disease, University of Lille, Lille, France.

Elodie Hainque (E)

Département de Neurologie, APHP, Paris, France.

Sophie Drapier (S)

Neurologie, CHU Pontchaillou, Rennes, France.

Béchir Jarraya (B)

Neuroscience, Hospital Foch, Suresnes, Île-de-France, France.

Chloé Laurencin (C)

CNRS UMR 5229, Bron, France.
Centre Expert Parkinson, Bron, France.

Dominique Guehl (D)

Pôle de Neurosciences Cliniques, CHU de Bordeaux, Bordeaux, France.
CNRS UMR 5293, Institut des Maladies Neurodegeneratives, Bordeaux, France.

Lucie Hopes (L)

Neurology, Centre Hospitalier Universitaire de Nancy, Nancy, Lorraine, France.

Christine Brefel-Courbon (C)

Clinical Pharmacology and Neurosciences, University Hospital Centre Toulouse, Toulouse, Occitanie, France.

Melissa Tir (M)

Neurology, CHU Amiens-Picardie, Amiens, Hauts-de-France, France.

Ana Marques (A)

EA7280, Université Clermont Auvergne, Clermont-Ferrand, France.
Neurology, University Hospital Centre Clermont-Ferrand, Clermont-Ferrand, France.

Tiphaine Rouaud (T)

Department of Neurology, Nantes University Hospital, Nantes, France.

David Maltete (D)

Neurology, Rouen University Hospital, Rouen, France.

Caroline Giordana (C)

Neurology, Centre Hospitalier Universitaire de Nancy, Nancy, Lorraine, France.

Karine Baumstarck (K)

Aix Marseille Université, EA 3279 Self-Perceived Health Assessment Research Unit, Marseille, France.

Olivier Rascol (O)

Pharmacology, Toulouse University, Toulouse, France.

Jean Christophe Corvol (JC)

Department of Neurology, Hopital Pitie-Salpetriere, Paris, France.

Anne-Sophie Rolland (AS)

Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's Disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Lille, France.

David Devos (D)

Medical Pharmacology, Lille University Medical Center, Lille, France.

Alexandre Eusebio (A)

APHM, Marseille, France.

Classifications MeSH